Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 10mg | $58.00 | $5.80/mg | In stock | Jul 8 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| 1671 | Mar 2026 | 99.8% | Vanguard Laboratory | Endotoxin, Sterility, Heavy metals | Confirmed | View |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. Ipamorelin is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Peptidology sell Ipamorelin?
Yes — Peptidology currently lists Ipamorelin in 1 variant starting at $58.00 ($5.80/mg).
Is Peptidology's Ipamorelin third-party tested?
Yes — Disclosed Labs has indexed 5 Certificates of Analysis for Peptidology's Ipamorelin, with the most recent showing 99.8% purity. Peptidology holds an overall trust grade of B (88/100) across all 162 COAs on file.
What is Peptidology's trust grade for Ipamorelin?
Peptidology has an overall Disclosed Labs trust grade of B (88/100), computed from 162 COAs across all peptides. The most recent Ipamorelin COA was issued by Vanguard Laboratory.
Where is the cheapest Ipamorelin?
As of the latest data, Peptide Supply Co. offers Ipamorelin at $2.70/mg — compare with Peptidology's listing at $5.80/mg. See the full Ipamorelin price comparison.
Is Ipamorelin legal to buy?
Ipamorelin is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| 1672 | Feb 2026 | 99.8% | Vanguard Laboratory | Endotoxin, Sterility, Heavy metals | Confirmed | View |
| 1665 | — | 99.8% | Vanguard Laboratory | Endotoxin, Sterility, Heavy metals | Confirmed | View |
| — | — | 99.5% | Vanguard Laboratory | Endotoxin, Heavy metals | Confirmed | View |
| 01-102-PD-1359 | — | 99.2% | Vanguard Laboratory | Endotoxin, Sterility, Heavy metals | Confirmed | View |
Disclosed Labs